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Coronavirus disease-2019 (COVID-19) was first diagnosed in Scotland on the 1st of March 
2020. During the first month of the outbreak, 2641 cases of COVID-19 led to 1832 hospital 
admissions, 207 intensive care admissions and 126 deaths. We aimed to identify the source 
and number of introductions of SARS-CoV-2 into Scotland using a combined phylogenetic 
and epidemiological approach.  Sequencing of 1314 SARS-CoV-2 viral genomes from 
available patient samples enabled us to estimate that SARS-CoV-2 was introduced to 
Scotland on at least 283 occasions during February and March 2020. Epidemiological 
analysis confirmed that early introductions of SARS-CoV-2 originated from mainland Europe 
(the majority from Italy and Spain). We identified subsequent early outbreaks in the 
community, within healthcare facilities, and at an international conference. Community 
transmission occurred after 2nd March, three weeks before control measures were introduced.  
Earlier travel restrictions or quarantine measures, both locally and internationally, would 
have reduced the number of COVID-19 cases in Scotland. The risk of multiple reintroduction 





The pandemic virus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has 
spread rapidly throughout the world following its emergence in Wuhan, China in December 
2019 (1-3). SARS-CoV-2 is a highly transmissible Betacoronavirus, related to the first SARS 
virus (4). It causes the clinical syndrome coronavirus disease-2019 (COVID-19), 
characterised by nonspecific respiratory or gastrointestinal viral symptoms and anosmia. In 
severe cases, acute respiratory distress syndrome, cardiovascular disease, neurological 
manifestations, thrombosis and renal failure may occur (5, 6). A rare Kawasaki-like disease 
has been described in children (7). Despite the mobilisation of significant resources to contain 
the outbreak, COVID-19 was declared a Public Health Emergency of International Concern 
(PHEIC) by the World Health Organisation on 30th January 2020 and a pandemic on 11th 
March 2020 (8, 9). Many countries are now responding to large outbreaks triggering 
unprecedented social and economic disruption and challenges to local healthcare systems.  
The WHO has declared a PHEIC on five occasions since 2009, all as a result of RNA virus 
outbreaks (H1N1 influenza, Zika, polio and Ebola). Pathogen genomic sequencing is now 
established as a core component of the modern epidemiological response to such outbreaks, 
driven by modern nucleic acid sequencing technologies that can rapidly yield entire pathogen 
genomes from clinical samples (10). The integration of viral genomic data with spatial, 
temporal and other metadata in a genomic epidemiology framework has allowed enhanced 
inference of the origin and transmission dynamics of disease outbreaks (11-13). Such an 
approach is particularly applicable to RNA viruses, as their relatively low-fidelity replication 
cycle generates mutations in the viral genome at a rate observable over the rapid time scale of 
an outbreak (14).  
In this study, we sequenced laboratory-confirmed cases of COVID-19 in Scotland, and 
analysed them alongside available international data, in order to estimate the number of 
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introduction events and early spread of SARS-CoV-2 in the country. During the sampling 
period, 2641 positive cases of COVID-19 were detected (https://www.opendata.nhs.scot, 
https://statistics.gov.scot), associated with 1832 hospital admissions, 207 intensive care 
admissions and 126 deaths. Applying a genomic epidemiology approach to the data, we 
demonstrate the outbreak is the result of multiple separate introductions of the virus 
associated with international travel, and that community transmission was quickly established 
in Scotland, well before the introduction of lockdown countermeasures on the 23rd March 





Multiple introductions of SARS-CoV-2 in Scotland. 1314 SARS-CoV-2 genomes were 
generated with >90% genome coverage, representing 49% of laboratory-confirmed Scottish 
COVID-19 cases (Extended Data Fig. 1). The median Ct value was 28.92 (interquartile range 
25.81-32.06). Of 1314 individuals, 976 (74%) reported no travel, and 114 (9%) reported travel 
outside Scotland in the two weeks preceding the onset of symptoms. No travel history was 
available for 224 (17%) of individuals. Countries visited included Italy (n=41), Spain (n=28), 
Austria (n=6), Switzerland (n=4), France (n=4), England (n=9), Wales (n=1), Germany (n=1), 
The Netherlands (n=1), Ireland (n=1), Poland (n=1), Cyprus, (n=1), Turkey (n=1), Argentina 
(n=1), Egypt (n=1), Tunisia (n=1), Canada (n=1), USA (n=2) and Thailand (n=1). Seven 
individuals returned from Caribbean cruise holidays. Samples were drawn from all regions of 
Scotland, with the exception of Orkney Islands, which had only three cases detected during the 
study period (Extended Data Fig. 2).  
The first case of COVID-19 in Scotland (CVR01) was a 51-year-old male from Tayside with 
mild respiratory symptoms who was tested on the 28th February 2020 (and reported positive on 
the 1st March 2020). He had returned from Italy after attending a rugby match 9 days earlier 
(15). The first confirmed case who had not travelled occurred three days later, on 2nd March 
2020 (CVR02). Reflecting the change from returning travellers to an older disease-susceptible 
demographic, the median age of cases increased from 44 (IQR 32-51) in the first week of the 
epidemic to 62 (IQR 47-76) in the fourth, as infections moved from travel-associated to local 
community transmission (Figure 1; Kruskal-Wallis test, p<0.001). A large proportion of 
sampled cases were healthcare workers and this increased from 5.9% during week 1 to 13.9% 
by week 4 of the outbreak (Extended Data Fig. 3). 
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To determine the relationship of the viruses identified in Scotland to global SARS-CoV-2 
variants, we inferred an evolutionary tree using viruses sequenced in this study against all 
complete genomes available from GISAID sampled prior to the 31st of March 2020 (GISAID 
= 9091, UK-ENG = 7801, UK-SCT = 1314, UK-WLS = 965, UK-NIR = 199) (Figure 2; 
Extended Data Fig. 1).  
 
While overall limited variability in the genome was observed in keeping with the lower 
evolutionary rate of coronaviruses compared to other RNA viruses and the recent 
introduction of the virus into the human population, the strains introduced into Scotland were 
diverse, representing much of the global distribution of lineages, with the majority fitting 
within lineage B (16) (Figure 2). Lineage A2 (n = 53) and A5 (n = 22) were the most 
prevalent A lineages; both are prevalent in Spain (47% of global A2 and 56% of A5 lineage 
sequences on GISAID derive from Spain). However, low sequencing coverage from some 
regions of the world (e.g., China) is likely to limit this assessment. Scottish sequences 
occurred throughout the B lineage with the largest number of sequences (n = 287) found 
within the B.1 lineage. Most Scottish lineages have also been detected in other parts of the 
UK, except for the marked absence of B.1.13 (UK sequences = 165 but 0 in Scotland). An 
increase in the number of sequences within the B.1, B.1.1, B.2 and B lineages coincided with 
the number of returning travellers from Italy and other parts of Europe in the first half of 
March, while the second half of March showed a rise in sequences within the A.2 lineage, 
coinciding with returning travellers from Spain and other parts of the UK (Extended Data  
Fig. 4).  
 
The 1314 Scottish genomes displayed an average of 3.6 nonsynonymous and 1.9 synonymous 
nucleotide substitutions in comparison to Wuhan-Hu-1 (Figure 3). Two common amino acid 
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replacements encoding 614D/G and 323P/L were observed in spike and nsp12, respectively 
and increased in prevalence over the first month of the epidemic (Figures 3A, 3B, 3C). 
Another spike replacement, N439K (reported by the CoVsurver receptor binding surveillance 
GISAID, https://www.gisaid.org/covsurver) occurred in addition to D614G in a Scottish 
cluster of 12 sequences. D614G has been hypothesised to be associated with increased 
transmissibility and escape from neutralisation (17) while N439K occurs at a predicted ACE2 
binding site. The 614G spike variant was introduced into Scotland an estimated 191 times in 
comparison to 91 for 614D and was the predominant variant sampled in March, with 807 
sequences compared to 504 for 614D. Three sequences lacked sufficient coverage at residue 
614 for the variant present to be determined, one of these being a singleton introduction. 
 
Introductions estimated based on phylogeny alone ranged from 234 (del_sct_lineage) to 1035 
(del_sct_introduction) if no attempt was made to merge sibling lineages at the polytomies. 
We combined the phylogeny, the travel history and date of sampling in order to refine these 
estimates. Merging sibling lineages provided a conservative phylogenetic estimate of 
introductions, but failed to identify lineages comprising multiple introductions, of which 
there are 17 examples within our dataset (Extended Data Fig.1). Conversely, failure to merge 
sibling lineages resulted in the inference of a large number of introductions that were 
unsupported by the available epidemiological data, for example, 7 individuals with no travel 
history who were known to have been infected through a superspreader event at a conference 
were counted as 7 separate introductions when the unmerged phylogenetic algorithm was 
applied (Extended Data Fig. 5). Combining the more conservative del_sct_lineage estimate, 
with the travel and temporal history permitted the confident identification of 283 independent 
introductions of SARS-CoV-2 into Scotland. In the majority of cases the phylogenetic 
lineage placement correlated well with the available epidemiological information for 
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introduction events. For example, all cases from two known superspreader events clustered 
together appropriately within single lineages, as did 8/12 of known household contacts. 
Interestingly, two household contacts (EDB006 and EDB035) with common exposure history 
through travel to Italy in early March had differing lineage assignments, suggesting 
acquisition of separate variants whilst travelling in a high-prevalence area at the time of 
exposure. A second pair of household contacts who had not travelled also had differing 
lineage assignments (EDB032 and EDB041) associated with 3 unique SNPs, again 
suggesting an alternative source of infection. 
 
Many of the introductions of COVID-19 into Scotland were from known returning travellers 
from Europe, mostly Italy (41 out of 283 introductions). 140/234 (59.8%) of phylogenetic 
lineages were single cases not linked with further cases over time. One hundred and eight of 
these singleton lineages were not associated with travel, likely corresponding to undetected 
introductions and community transmission clusters. There were 94 phylogenetic lineages of 
at least two individuals associated with transmission in varied community settings (Figures 
4A-C), for example, in the Shetland Islands with travel links to Italy, associated with a care 
home facility, community transmission across central Scotland, and transmission related to an 
international conference event in Edinburgh at the end of February prior to the first 
documented SARS-CoV-2 case in Scotland (Extended Data Fig. 5). The latter demonstrates 
the extent to which conferences and other large gatherings act as superspreader events and 
contribute to intensified spreading of the virus, supporting findings from similar events in 
China and Singapore (18, 19). Time-scaled trees were carried out in order to estimate the 
timing of undetected introductions in Scotland in lineages with no associated epidemiological 
travel history (Figure 5). These inferred first introductions dated back as far as the 19th 
February 2020, indicating that community transmission was likely to have occurred 
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undetected up to 1-2 weeks earlier than the first detected cases. This is in keeping with 
previously published seroprevalence data from the Scottish blood transfusion service (20).  
 
Shift to community transmission. Ninety introductions (32%) were linked 
epidemiologically to travel in Europe, seven (2.5%) were linked to Caribbean cruises and 
seven (2.5%) to travel to the rest of the world. The first case of documented community 
transmission occurred on the 2nd March 2020 and community transmission was well-
established by the 11th March (Figures 1, 4A-C). Figure 4A represents a large cluster which 
spread across the Scottish central belt between the 13th March and 31st March with no known 
associated travel. A cluster occurring between the 6th and 30th March focused on the Shetland 
Islands contained two index cases with travel history to Italy (Figure 4B) but all subsequent 
cases in the cluster did not report travel. This shift to community transmission is evident in 
other example clusters: Figure 4C represents a cluster from a care home. We also investigated 
the possibility of local transmission chains in healthcare settings. As described above, 
healthcare workers were noted to represent some of the earliest cases, with an increase in 
cases over time (Extended Data Fig. 3). However, at the beginning of the outbreak, not all 
cases were community acquired and it was possible to exclude cases of potential nosocomial 
transmission by comparing sequences from patients on the ward with that of the HCW. For 
example, a HCW, CVR10 (Extended Data Fig. 1), showed evidence of infection from a virus 
strain distinct from other samples from the same hospital within lineage B.2.2, whilst the 
ward patient sequences were from lineages B.1.5(CVR76), B.2.1(CVR07) and B.1.10 
(CVR79), indicating community rather than nosocomial infection. The increase in cases over 
time is likely to reflect a combination of increased testing in HCWs and nosocomial 





Our study indicates that SARS-CoV-2 entered the Scottish population through at least 283 
separate travel-related introductions. This estimate was calculated using a combination of 
phylogenetic lineage and epidemiological data. In isolation, each dataset would have resulted 
in an under-estimate of the number of introductions due to the slow rate of evolution of the 
SARS-CoV-2 virus and absence of detection of travel-related incident cases respectively. 
There were 234 phylogenetic lineages, of which 94 (40%) were associated with sustained 
community transmission (containing at least 2 Scottish sequences without a history of travel) 
and 140 (60%) singleton sequences with no evidence of onward transmission. 34/94 (36%) of 
phylogenetic lineages associated with onward transmission involved individuals with a 
known history of international travel. The majority returned to Scotland from Europe at the 
end of February and early March following travel to Italy and less commonly to Spain, 
Austria, Switzerland, France, England, Ireland, Poland, the Caribbean and Thailand. While 
the first positive case occurred on the 1st March 2020, evidence of community transmission 
during late February 2020 was supported by epidemiological data and by time-scaled 
phylogenetic analysis. A shift from travel-associated infection in younger adults to 
community transmission in older adults and in healthcare workers was noted throughout the 
first month of the epidemic. 
 
On the 28th January, the UK government recommended against all but essential travel to 
China and for returning travellers to self-isolate for two weeks upon their return regardless of 
symptoms (21). However, in this study, cases with direct links to Southeast Asia were rare 
(only one case associated with travel to Thailand was detected through epidemiological 
analysis). In contrast, travel to continental Europe in February and March 2020, by then the 
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epicentre of the global COVID-19 pandemic, was a clear driver of the Scottish outbreak; the 
majority of the lineages detected in this study were lineage B and related to European 
sequences. Lineage A, a lineage with a distribution more limited to China at the beginning of 
the outbreak, was introduced to Scotland on at least ten occasions. The travel history and 
phylogenetic analysis of these cases indicated that the majority of these occurred via Spain. 
One introduction was potentially attributable to importation from China (and one from the 
USA) based on phylogenetic evidence alone. Despite evidence of local transmission in Italy 
as early as February 21st, the advice from the Scottish Government for returning travellers 
from Italy to self-isolate was issued only on the 25th of February and was limited to those 
having returned from specific lockdown areas (22-24). By the time this advice was extended 
to all travellers on 10th March, the COVID-19 outbreak within Scotland was already being 
driven by community transmission. A lack of robust measures to manage ingress of high 
numbers of infected travellers from rapidly emerging pandemic hotspots may have 
accelerated the course of the outbreak in Scotland and the UK as a whole.  
 
Our data demonstrate that SARS-CoV-2 was introduced to Scotland on many hundreds of 
occasions, so no single event can be considered to have ‘sparked’ the epidemic in the rest of 
the country. One notable introduction event at the beginning of the outbreak occurred at an 
international conference held in Edinburgh during late February, several days before the first 
Scottish case was confirmed. Several cases were linked to this event, with the last case within 
the cluster in the UK occurring on the 27th March, showing that the local public health 
response was effective in controlling spread. However, the geographical distribution of 
related sequences is striking, spanning four continents and ten countries. The role of this 
event in local dispersal of the virus, before a single case had been identified in Scotland, 
demonstrates that governments should be wary of prematurely relaxing restrictions on large 
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gatherings and international travel. Importantly, the directionality of transmission cannot be 
inferred from the phylogeny; SARS-CoV-2 could have been introduced from the Netherlands 
and other countries to Scotland, exported from Scotland or both. 
 
In parallel with the above introduction, we identified other viral lineages with no 
epidemiological link to travel as early as three days after the first detection of infection, 
suggesting earlier introduction to Scotland than the first detected case, reported on the 1st 
March 2020 (15). This is supported by the analysis of time-scaled phylogenies, which infers a 
common ancestor from mid-late February for some Scotland-specific clades. The majority of 
individuals had no recorded link to travel by the 12th March, only 2 days after substantial 
travel and physical distancing restrictions were put in place. Importantly these data are 
suggestive of introductions and community spread well before initial detection. The epidemic 
in the UK expanded rapidly, prompting the government to respond with restrictive public 
health measures or “lockdown” to disrupt transmission. These phylogenetic data will provide 
a baseline for granular real-time sequencing of infections as cases rise and fall over time and 
will be used as a measure of the success of current measures with the potential to contribute 
to decision-making around the easing (or tightening) of public health measures. In this study, 
the use of epidemiology or phylogenetic lineage assignment alone would have resulted in an 
under-estimate of the number of introductions of the virus (114 and 234 respectively) due to 
undetected cases reaching the attention of public health authorities and due to the slow rate of 
evolution of the virus. Integration of genomic sequence data with traditional case-finding and 
contact tracing has the potential to enhance descriptive epidemiology and deliver more 
targeted control measures. However previous interventions of this type have been largely 
retrospective. The challenge will be to develop a framework where phylogenetic information 
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is delivered in real-time in an easily actionable format to public health and infection control 
teams.  
This study has some limitations. We sampled only around half of positive samples detected 
during the initial outbreak, therefore some introduction events will have been missed. 
Further, while laboratory and hospital case notes were available for review, public health 
records were not accessed to record linkage with sequence data. Our analysis is likely to have 
been affected by a shift in sampling all symptomatic individuals to hospitalised patients and 
healthcare workers only during mid-March. Some travel-related introductions may therefore 
not have been detected (as evidenced by several clusters with no evidence of travel related 
infection after this time) and healthcare workers may have been over-sampled in the analysis. 
While introduction of erroneous variation during sequencing or genome assembly is possible, 
we estimated experimentally that such rates were extremely low and should not affect 
clustering patterns in phylogenetic analyses. This analysis, based on the available phylogeny, 
is most likely to be an under-estimate, despite dense sampling of the beginning of the 
outbreak, as many events may be linked to an identical sequence due to the slow evolution of 
SARS-CoV-2. Several events that we counted as introductions were based on 
epidemiological history but could not be resolved by phylogeny alone. The slow evolutionary 
rate of the virus also means that linkage of sequences does not categorically prove that 
transmission events have occurred and require correlation with epidemiological information. 
Exclusion of linkage may be inferred with more certainty. Nevertheless, as the variation 
present within the global diversity is well-represented in Scotland, reflecting a high number 
of near simultaneous introductions, tracking of the outbreak is feasible and can be used to 
refine public health interventions. Finally, as further sequence data becomes available from 
other countries, the topology of the global tree is predicted to change, which is likely to have 
the effect of a slight increase in our estimate of introductions. 
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In summary, the first month of the COVID-19 outbreak in Scotland was associated with 
multiple introductions related to returning travellers from Europe, early community 
transmission, and clusters related to large indoor events and healthcare facilities. An earlier 
lockdown from countries with a high burden of cases such as Italy and other measures such 
as quarantine of travellers from high-risk areas might have prevented escalation of the 
outbreak and multiple clusters of ongoing community transmission. Combining genomic data 
with epidemiological data has the potential to inform public health intervention policy. 
Multiple travel-associated introductions during the first wave of infection in Scotland 
highlight this as a significant risk for re-introduction in future waves. 
 
Data availability statement 
All consensus genomes are available from the GISAID database (https://www.gisaid.org), the 
COG-UK consortium website (https://www.cogconsortium.uk/data/) and BAM files from the 
European Nucleotide Archive’s Sequence Read Archive service, BioProject PRJEB37886 
(https://www.ebi.ac.uk/ena/data/view/PRJEB37886). See Source Data Table 1 for IDs and 
dates of sampling. 
Code availability statement 
Reads were size filtered, demultiplexed and trimmed with Porechop 
(https://github.com/rrwick/Porechop v0.2.4). The ARTIC bioinformatic pipeline v1.1.3 
(https://github.com/artic-network/artic-ncov2019) was used for generation of consensus 
sequences. The grapevine pipeline (https://github.com/COG-UK/grapevine) was used for 
generating the phylogeny based on all data available on GISAID and COG-UK up until 23-
08-2020. Sequence typing was carried out using PANGOLIN  (https://github.com/hCoV-
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2019/pangolin v2.0.5). Scottish clusters were investigated following the DELTRAN 




Samples. Up to 300 samples per week were selected prospectively following ethical approval 
from the relevant national biorepository authorities (16/WS/0207NHS and10/S1402/33) 
between 1st March and 1st April 2020. This work was conducted as part of the UK 
Government funded Covid-19 Genomics (COG-UK) consortium, which was set up in March 
2020 and aims to provide representative, large-scale and rapid whole genome virus 
sequencing across the United Kingdom (25). 50% of samples were randomly selected to 
achieve a representative target for all Scottish health boards and 50% to cover suspected 
healthcare-related nosocomial infections as they occurred. Health boards with a small 
population size were reported at a minimum of 5 sequences per region to avoid deductive 
disclosure. The Royal Infirmary of Edinburgh (RIE) and West of Scotland Specialist 
Virology Centre, NHSGGC conducted diagnostic real-time RT-PCR to detect SARS-CoV-2 
positive samples, following nucleic acid extraction utilising the NucliSENS® EasyMag® and 
Roche MG96 platforms (26). Residual nucleic acid from 1314 samples underwent whole 
genome next generation sequencing at the MRC-University of Glasgow Centre for Virus 
Research (CVR) and the RIE. Clinical details including recent travel history were obtained 
from assay request forms submitted to the diagnostic laboratory, and where available 
electronic patient records and local public health databases. A travel history was defined as 
travel from any country (including England, Wales and Northern Ireland) by any means of 
transport including by air, ferry, train and car within the two weeks prior to the onset of 
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symptoms. Statistical comparisons (two-tailed) were carried out using R version 3.6.3 by 
Kruskal-Wallis test. 
 
Rapid sequencing protocol using Oxford Nanopore Technologies (ONT) Following 
extraction, libraries were prepared utilising protocols developed by the ARTIC network (v1 
and v2) https://artic.network/ncov-2019. 50 fmol of library pools were loaded onto each flow 
cell (R9.4.1). Sequencing was conducted in MinKNOW version 19.12.5. Raw FAST5 files 
were basecalled using Guppy version 3.4.5 in high accuracy mode using a minimum quality 
score of 7. RAMPART v1.0.5 was used to visualise read mapping in real-time. Reads were 
size filtered, demultiplexed and trimmed with Porechop (https://github.com/rrwick/Porechop 
v0.2.4), and mapped against reference strain Wuhan-Hu-1 (MN908947). Variants were called 
using Nanopolish 0.11.3 and accepted if they had a log-likelihood score of greater than 200 
and minimum read coverage of 20 following the ARTIC bioinformatic pipeline v1.1.3 
(https://github.com/artic-network/artic-ncov2019). This protocol was used by CVR and RIE 
sites. 
  
High throughput sequencing protocol using Illumina MiSeq. Amplicons were generated 
as described above. DNA fragments were cleaned using AMPURE beads (Beckman Coulter) 
and 40ng used to prepare Illumina sequencing libraries with a DNA KAPA library 
preparation kit (Roche). Indexing was carried out with NEBNext multiplex oligos (NEB), 
using 7 cycles of PCR. Libraries were pooled in equimolar amounts and loaded on a 
MiSeqV2 cartridge (500 cycles). Reads were trimmed with trim_galore 
(http://www.bioinformatics.babraham.ac.uk/projects/trim_galore/ v0.6.5) and mapped with 
BWA (27) to the Wuhan-Hu-1 (MN908947) reference sequence, followed by primer 
trimming and consensus calling with iVar v1.2.2 (28) and a minimum read coverage of 10. 
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This protocol was followed by the CVR site whereas samples sequenced at the Wellcome 
Sanger Institute (labelled with the prefix GCVR) follow a diverse Illumina library preparation 
method and use the NovaSeq instrument. Consensus sequence data was highly correlated 
between different sequencing platforms. 
 
Sequence Data. Consensus sequences with >90% coverage were included. All consensus 
genomes are available from the GISAID database (https://www.gisaid.org), the COG-UK 
consortium website (https://www.cogconsortium.uk/data/) and BAM files from the European 
Nucleotide Archive’s Sequence Read Archive service, BioProject PRJEB37886 
(https://www.ebi.ac.uk/ena/data/view/PRJEB37886). See ource data Table 1 for IDs and 
dates of sampling. Amplicon-based sequencing using Illumina instruments has previously 
been applied to RNA viruses for accurate identification of intra-host variants, with 
performance comparable to metagenomics (28). A similar protocol has been applied to 
dengue virus using multiplex PCR tiling on Oxford Nanopore sequencer, resulting in 99.69- 
99.92% consensus identity when compared to those produced by Illumina (29). In order to 
minimise consensus level errors in regions of lower genome coverage and in samples with 
very low viral load (28), we opted to exclude samples with poor genome coverage (<90%), 
typically associated to low viral load while a) sequencing at a high depth with an average of 
5000X per sample (CVR), or b) actively excluding low viral load samples (Ct>30) while 
sequencing at an average depth of 500X (RIE).  
 
 
Phylogenetic analysis. The grapevine pipeline (https://github.com/COG-UK/grapevine) was 
used for generating the phylogeny based on all data available on GISAID and COG-UK up 
until 23-08-2020. Briefly, the pipeline cleans and filters reads based on quality and consensus 
19 
 
coverage, aligns the sequences to the reference, types the sequences using PANGOLIN  
(https://github.com/hCoV-2019/pangolin v2.0.5), merges the COG-UK sequences with the 
GISAID alignment, masks homoplasies (position 11083 relative to Wuhan-Hu1) and 
reconstructs the maximum likelihood phylogeny using FastTree v2.1.11 (30). 
Wuhan/WH04/2020 was used as an outgroup for the phylogeny. Finally, the phylogeny was 
pruned to keep only sequences prior to 31-March-2020 to retrospectively investigate the 
introductions into Scotland alongside known travel history and epidemiological information. 
Scottish clusters were investigated following the DELTRAN implementation method (31) 
with the following four steps using clusterfunk (https://github.com/cov-ert/clusterfunk 
v0.0.3): 1) Scottish and non-Scottish sequences were coded as a binary trait and annotated on 
the tree, 2) The ancestral state of the Scottish trait was reconstructed on the phylogeny, 3) 
Transition nodes from non-Scottish to Scottish were identified as “DELTRAN Scottish 
introductions” on the tree (del_sct_introductions), 4) Transitions were then merged such that 
sibling introductions are clustered together ensuring that identical sequences were given the 
same “DELTRAN Scottish lineage” number (del_sct_lineage). This is a fully automated 
approach which has some caveats: due to the slow evolutionary rate of the virus, the tree has 
many polytomies and thus the parsimony reconstruction of a trait on the tree becomes 
ambiguous, hence, the need to merge sibling introductions together. Additionally, where 
there are exports and subsequent re-introductions (unlikely during the first month of the 
outbreak), the DELTRAN approach would label these as the ancestral introduction.  
Due to the relatively low evolutionary rate of SARS-CoV2, it is often difficult to differentiate 
introductions on the basis of the phylogeny alone, as sequences from distinct introductions 
may be identical or cluster on the phylogeny (thereby under-estimating introductions) and 
incorporation of the assumption that identical sequences at the base of the tree represent 
distinct introductions may result in an over-estimate. In order to refine the phylogenetic 
20 
 
estimate of the number of times the virus was introduced into Scotland we used the more 
conservative del_sct_lineage as a framework upon which we layered available 
epidemiological and temporal data. Lineages with no known travel related cases were 
counted as a single introduction regardless of the number of taxa present. Multiple travel 
related cases within a lineage were each classed as separate introductions. Where a single 
travel related case was recorded within a phylogenetic lineage this was counted as a single 
introduction if it occurred up to 14 days after the first case in the cluster. If the travel related 
case returned to Scotland after the lineage had already been detected, or if the travel related 
case was sampled more than 14 days following the first detection of the lineage within 
Scotland, it was counted as a further introduction. 
  
Seven large UK lineages that were predominantly sampled from Scotland were investigated 
further using time-scaled trees with treetime (32) (clock-rate of 0.001 and 10 iterations) in 
order to give an indication of the detection lag (time between the most recent common 
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Figure Legends  
 
Figure 1. Spatial and demographic features of sequenced cases. (A) Histogram of daily 
cases stratified by confirmed travel history. (B) Ages of positive cases referred for diagnostic 
testing to the WOSSVC by week of the outbreak in Scotland (showing median (middle bar), 
interquartile range (box), range (vertical line) and outliers). Median age increased from 44 in 
week one (n=12, IQR 18.8) to 50 in week 2 (n=52 IQR 25.8), 61 in week 3 (n = 183 IQR 
30.5), and 62 (n=516 IQR 29) in week 4 (Kruskal-Wallis rank sum test, H = 27.47, df = 3, p 
< 0.001). (C) Spatial distribution and associated travel history over the first four weeks of the 
outbreak. Testing of community cases ceased on day a1 of week 3 (14th March) and 
lockdown occurred on day 2 of week 4 (23rd March). 
Figure 2. Phylogenetic relationships of Scottish genomes to all SARS-CoV-2 genomes. 
Known travel histories are indicated (see keys). Global sequence data were available from 
GISAID. Non-Scottish sequences were subsampled for presentation purposes by keeping a 
single sequence per date/country/lineage reducing the total number of non-Scottish sequences 
from 17578 to 5389. The scale bar indicates substitutions per nucleotide site.  
Figure 3. Detection of polymorphisms within the SARS-CoV-2 genome (A) Frequency of 
amino acid residue at position 614 in spike protein for Scottish sequences in March (D - 
aspartate, G - glycine, X - undetermined). (B) Amino acid residue at spike 614 for each 
Scottish lineage introduction by date of first detection. (C) A visualisation of the genetic 
variation across the entire genome observed in the 1314 SARS-CoV-2 genomes in Scotland. 
Nonsynonymous (pink) and synonymous (green) substitutions (with respect to Wuhan-Hu-1, 
GenBank accession number MN908947) are represented in colour in each row. The 
mutations are plotted in a grid format where each row is a sample and each column is a 
unique genome position; mutations have been filtered to only display those observed in more 
28 
 
than two samples. Mutation labels have been added into the heatmap showing the genome 
position and ORF name with amino acid number/mutation (non-synonymous mutation details 
are highlighted in bold). Labels for each of the ORFs of the SARS-CoV-2 genome are shown 
in the lower panel. The plot was created using the d3heatmap package in R with samples 
(rows) ordered according to Ward’s clustering. 
 
Figure 4. Selected phylogenetic clusters associated with introduction events (A) A spatially 
distributed outbreak across the Central Scotland belt without any known links to travel, (B) A 
cluster focused on Shetland associated with two linked cases with travel to Italy, (C) a focal 
outbreak in a residential facility not associated with any known travel. 
Figure 5: Time-scaled trees in lineages with no associated epidemiological travel history 
Time scaled trees were produced with treetime (clock-rate of 0.001 and 10 iterations) for 7 
established lineages in order to give an indication of the detection lag (time between the most 
recent common ancestor and the first sequenced sample). Scottish lineage numbers are 




























































































































































































































Cases (n) 1 5 10

































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Extended Data Figure 2 
 
 















































Caribbean CruiseItaly North America Other European
Asia and South America Rest of UKSpain
country
Australia
Austria
Belgium
Denmark
Ecuador
Finland
France
Germany
Iceland
Israel
Netherlands
New_Zealand
Portugal
Singapore
Slovakia
Spain
Sweden
UK
USA
3.0E-5
Germany/BY-MVP-0018/2020_2020-03-25
Netherlands/NoordBrabant_32/2020_2020-03-08
Singapore/351/2020_2020-03-28
Netherlands/NA_181/2020_2020-03-22
England/PHEC-10067/2020_2020-03-02
Netherlands/NoordBrabant_48/2020_2020-03-11
England/PHEC-1B318/2020_2020-02-27
Scotland/CVR80/2020_2020-03-05
Belgium/UGent-15/2020_2020-03-25
Netherlands/NA_105/2020_2020-03-18
Netherlands/NA_668/2020_2020-03-10
Netherlands/NoordBrabant_10042/2020_2020-03-25
Netherlands/NA_211/2020_2020-03-25
Netherlands/NA_674/2020_2020-03-10
England/PHEC-187C4/2020_2020-03-18
England/PHEC-1AD2A/2020_2020-03-05
Netherlands/NoordBrabant_10/2020_2020-03-02
England/PHEC-1A56E/2020_2020-03-03
Netherlands/NA_113/2020_2020-03-10
Netherlands/NA_270/2020_2020-03-30
England/PHEC-1A74A/2020_2020-03-05
England/NORT-295E5F/2020_2020-03-31
Scotland/EDB012/2020_2020-03-07
England/PHEC-204E0/2020_2020-03-02
Netherlands/NA_137/2020_2020-03-19
Slovakia/SK-BMC6/2020_2020-03-08
Scotland/EDB002/2020_2020-03-05
Singapore/101/2020_2020-03-16
Austria/CeMM0191/2020_2020-03-13
Netherlands/ZuidHolland_48/2020_2020-03-19
England/PHEC-1AF06/2020_2020-03-06
Netherlands/NoordBrabant_113/2020_2020-03-20
Austria/CeMM0388/2020_2020-03-19
Spain/Valencia294/2020_2020-03-17
Scotland/CVR817/2020_2020-03-27
Belgium/UGent-77/2020_2020-03-25
Scotland/GCVR-17079C/2020_2020-03-25
England/PHEC-12320/2020_2020-03-27
Portugal/PT0041/2020_2020-03-17
England/BRIS-1217B8/2020_2020-03-04
Sweden/20-05983/2020_2020-03-18
England/PHEC-125C0/2020_2020-03-27
England/NORT-281AF8/2020_2020-03-23
Netherlands/NA_58/2020_2020-03-08
Netherlands/NA_141/2020_2020-03-19
Belgium/GGO-0327349/2020_2020-03-27
Netherlands/NA_33/2020_2020-03-07
England/PHEC-1AA32/2020_2020-03-05
England/PHEC-2050B/2020_2020-03-02
Sweden/20-08133/2020_2020-03-10
Netherlands/NA_39/2020_2020-03-14
England/PHEC-1AF60/2020_2020-03-05
England/PHEC-1ADEE/2020_2020-03-05
England/PHEC-1ACB4/2020_2020-03-06
Netherlands/Hardinxveld_Giessendam_1364806/2020_2020-03-02
England/PHEC-2040E/2020_2020-03-02
Netherlands/NA_287/2020_2020-03-31
Netherlands/NoordBrabant_87/2020_2020-03-09
Netherlands/NoordBrabant_114/2020_2020-03-21
England/PHEC-1BCD1/2020_2020-03-02
Belgium/UGent-17/2020_2020-03-26
Belgium/UGent-94/2020_2020-03-13
England/NORT-28115D/2020_2020-03-05
France/ARA07731/2020_2020-03-11
England/BRIS-12F6DB/2020_2020-03-08
England/PHEC-1AE72/2020_2020-03-06
England/PHEC-1ACC3/2020_2020-03-06
Netherlands/ZuidHolland_94/2020_2020-03-31
Netherlands/NoordBrabant_80/2020_2020-03-11
England/PHEC-1AB11/2020_2020-03-05
England/PHEC-1ACA5/2020_2020-03-06
England/PHEC-19365/2020_2020-03-11
Netherlands/NoordBrabant_42/2020_2020-03-10
Netherlands/NA_629/2020_2020-03-24
Netherlands/Gelderland_9/2020_2020-03-18
USA/MN2-MDH2/2020_2020-03-07
Netherlands/Utrecht_14-2/2020_2020-03-09
Scotland/GCVR-170BAF/2020_2020-03-25
England/PHEC-10AE1/2020_2020-03-18
Netherlands/Nieuwendijk_1363582/2020_2020-03-01
England/NOTT-10DF9C/2020_2020-03-14
England/PHEC-1A2D0/2020_2020-03-10
Germany/NRW-15/2020_2020-03-11
Scotland/CVR118/2020_2020-03-12
USA/NY-Wadsworth-30164-01/2020_2020-03-26
Israel/CVL-n-6100/2020_2020-03-15
Netherlands/NA_133/2020_2020-03-11
Netherlands/NoordBrabant_27/2020_2020-03-08
Belgium/UGent-1/2020_2020-03-24
England/CAMB-746BA/2020_2020-03-29
Netherlands/NA_182/2020_2020-03-22
Netherlands/NA_214/2020_2020-03-25
Netherlands/NoordBrabant_83/2020_2020-03-11
England/PHEC-1AD48/2020_2020-03-05
Netherlands/ZuidHolland_32/2020_2020-03-09
Belgium/UGent-19/2020_2020-03-24
Finland/14M82/2020_2020-03-14
England/NORT-281CD4/2020_2020-03-24
Scotland/CVR65/2020_2020-03-06
Netherlands/NA_178/2020_2020-03-22
Netherlands/NA_135/2020_2020-03-19
Netherlands/NoordBrabant_35/2020_2020-03-09
England/SHEF-BFD54/2020_2020-03-02
England/PHEC-1AE36/2020_2020-03-06
England/PHEC-1A416/2020_2020-03-10
Scotland/CVR71/2020_2020-03-06
England/LIVE-A489D/2020_2020-03-13
Spain/Valencia133/2020_2020-03-18
England/SHEF-BFC93/2020_2020-03-03
Netherlands/NoordBrabant_93/2020_2020-03-09
Scotland/GCVR-1713D3/2020_2020-03-26
England/SHEF-C087D/2020_2020-03-25
Netherlands/NA_112/2020_2020-03-10
Netherlands/NA_67/2020_2020-03-09
Denmark/ALAB-SSI-1250/2020_2020-03-11
Netherlands/NoordBrabant_92/2020_2020-03-24
England/PHEC-1A917/2020_2020-03-04
England/PHEC-1A65C/2020_2020-03-03
Netherlands/NA_132/2020_2020-03-11
Netherlands/ZuidHolland_95/2020_2020-03-31
Scotland/GCVR-1712A9/2020_2020-03-26
England/PHEC-10489/2020_2020-03-06
Scotland/CVR75/2020_2020-03-06
England/PHEC-1A58C/2020_2020-03-04
England/PHEC-19D1C/2020_2020-03-07
England/PHEC-1AC5A/2020_2020-03-04
Netherlands/Zeeland_19/2020_2020-03-24
England/PHEC-1AD0C/2020_2020-03-04
England/PHEC-1A777/2020_2020-03-04
Scotland/CVR02/2020_2020-03-02
Netherlands/NoordBrabant_94/2020_2020-03-17
Iceland/522/2020_2020-03-25
England/PHEC-1A768/2020_2020-03-04
England/PHEC-1035F/2020_2020-03-04
England/PHEC-1A7C2/2020_2020-03-05
Netherlands/NA_22/2020_2020-03-08
Netherlands/Utrecht_10012/2020_2020-03-14
Netherlands/NoordBrabant_30/2020_2020-03-08
Austria/CeMM0080/2020_2020-03-24
Netherlands/NoordBrabant_10039/2020_2020-03-16
England/PHEC-1ADC0/2020_2020-03-05
Netherlands/Gelderland_10/2020_2020-03-20
Netherlands/NA_68/2020_2020-03-09
Netherlands/NA_41/2020_2020-03-13
Netherlands/NoordBrabant_12/2020_2020-03-06
Netherlands/NoordBrabant_111/2020_2020-03-11
New_Zealand/20VR0995/2020_2020-03-17
England/PHEC-1AD39/2020_2020-03-05
Netherlands/NA_233/2020_2020-03-27
Scotland/CVR304/2020_2020-03-21
England/CAMB-84A51/2020_2020-03-10
Austria/CeMM0566/2020_2020-03-27
England/SHEF-C06CE/2020_2020-03-25
England/PHEC-2041D/2020_2020-03-03
England/CAMB-84B7C/2020_2020-03-10
Netherlands/NoordBrabant_31/2020_2020-03-08
Netherlands/NoordBrabant_10003/2020_2020-02-28
England/PHEC-20389/2020_2020-03-04
Netherlands/NoordBrabant_99/2020_2020-03-19
Netherlands/Utrecht_10007/2020_2020-03-05
England/PHEC-1A407/2020_2020-03-10
Netherlands/NoordBrabant_29/2020_2020-03-08
Netherlands/NoordBrabant_115/2020_2020-03-22
England/PHEC-19338/2020_2020-03-09
England/PHEC-1BCE0/2020_2020-03-02
Netherlands/NoordBrabant_116/2020_2020-03-23
England/PHEC-1B390/2020_2020-03-27
Netherlands/NA_180/2020_2020-03-23
Netherlands/NoordBrabant_28/2020_2020-03-08
Netherlands/NoordBrabant_54/2020_2020-03-09
Scotland/CVR04/2020_2020-03-04
Ecuador/HEE-01/2020_2020-03-09
Netherlands/Tilburg_1363354/2020_2020-02-27
Australia/QLDID928/2020_2020-03-19
England/PHEC-20486/2020_2020-03-03
USA/CA-SCCPHD-UC141/2020_2020-03-09
England/PHEC-1BCFF/2020_2020-03-02
Netherlands/NoordBrabant_97/2020_2020-03-19
England/GSTT-265E1B9/2020_2020-03-31
England/PHEC-110EE/2020_2020-03-18
Attended 
conference
Contact of
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